SCHEMBL4459245

SCHEMBL4459245

NC1=NC(N)(c2cc(Br)ccc2Br)NC=C1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 4/20 0.31
APP P05067 2/20 0.31
PDPK1 O15530 2/20 0.30
JAK2 O60674 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4459721 0.88 PDPK1 (0.30) PDPK1JAK2
SCHEMBL4458379 0.71 CYP3A4 (0.35)
SCHEMBL1172224 0.68 BACE1 (0.32) BACE1
SCHEMBL1172351 0.66 BACE1 (0.38) BACE1APP
SCHEMBL1172247 0.65 ALDH1A1 (0.41)
SCHEMBL4462368 0.65 HTR5A (0.32)
SCHEMBL1171761 0.64 APP (0.32) BACE1APP
SCHEMBL1171746 0.64 CTSD (0.32) BACE1
SCHEMBL1171733 0.62 KDM1A (0.39) BACE1APP
SCHEMBL1172133 0.62 BACE1 (0.39) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed